Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Prefrontal dopamine D1 receptors and working memory in schizophrenia.

Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang DR, Keilp J, Kochan L, Van Heertum R, Gorman JM, Laruelle M.

J Neurosci. 2002 May 1;22(9):3708-19.

2.

PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.

Abi-Dargham A, Simpson N, Kegeles L, Parsey R, Hwang DR, Anjilvel S, Zea-Ponce Y, Lombardo I, Van Heertum R, Mann JJ, Foged C, Halldin C, Laruelle M.

Synapse. 1999 May;32(2):93-109.

PMID:
10231129
3.

Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia.

Guo N, Hwang DR, Lo ES, Huang YY, Laruelle M, Abi-Dargham A.

Neuropsychopharmacology. 2003 Sep;28(9):1703-11. Epub 2003 Jun 18.

4.

Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys.

Tsukada H, Nishiyama S, Fukumoto D, Sato K, Kakiuchi T, Domino EF.

Neuropsychopharmacology. 2005 Oct;30(10):1861-9.

5.

Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.

Halldin C, Foged C, Chou YH, Karlsson P, Swahn CG, Sandell J, Sedvall G, Farde L.

J Nucl Med. 1998 Dec;39(12):2061-8.

6.

Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [¹¹C]NNC112.

Thompson JL, Rosell DR, Slifstein M, Girgis RR, Xu X, Ehrlich Y, Kegeles LS, Hazlett EA, Abi-Dargham A, Siever LJ.

Psychopharmacology (Berl). 2014 Oct;231(21):4231-40. doi: 10.1007/s00213-014-3566-6. Epub 2014 Apr 30.

7.

Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.

Slifstein M, van de Giessen E, Van Snellenberg J, Thompson JL, Narendran R, Gil R, Hackett E, Girgis R, Ojeil N, Moore H, D'Souza D, Malison RT, Huang Y, Lim K, Nabulsi N, Carson RE, Lieberman JA, Abi-Dargham A.

JAMA Psychiatry. 2015 Apr;72(4):316-24. doi: 10.1001/jamapsychiatry.2014.2414.

8.

Altered prefrontal dopaminergic function in chronic recreational ketamine users.

Narendran R, Frankle WG, Keefe R, Gil R, Martinez D, Slifstein M, Kegeles LS, Talbot PS, Huang Y, Hwang DR, Khenissi L, Cooper TB, Laruelle M, Abi-Dargham A.

Am J Psychiatry. 2005 Dec;162(12):2352-9.

PMID:
16330601
9.

PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.

Karlsson P, Farde L, Halldin C, Swahn CG, Sedvall G, Foged C, Hansen KT, Skrumsager B.

Psychopharmacology (Berl). 1993;113(2):149-56.

PMID:
7855175
10.
11.
12.

Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility.

Abi-Dargham A, Martinez D, Mawlawi O, Simpson N, Hwang DR, Slifstein M, Anjilvel S, Pidcock J, Guo NN, Lombardo I, Mann JJ, Van Heertum R, Foged C, Halldin C, Laruelle M.

J Cereb Blood Flow Metab. 2000 Feb;20(2):225-43.

PMID:
10698059
13.

Increased prefrontal cortical D₁ receptors in drug naive patients with schizophrenia: a PET study with [¹¹C]NNC112.

Abi-Dargham A, Xu X, Thompson JL, Gil R, Kegeles LS, Urban N, Narendran R, Hwang DR, Laruelle M, Slifstein M.

J Psychopharmacol. 2012 Jun;26(6):794-805. doi: 10.1177/0269881111409265. Epub 2011 Jul 18.

PMID:
21768159
14.

Reduced but broader prefrontal activity in patients with schizophrenia during n-back working memory tasks: a multi-channel near-infrared spectroscopy study.

Koike S, Takizawa R, Nishimura Y, Kinou M, Kawasaki S, Kasai K.

J Psychiatr Res. 2013 Sep;47(9):1240-6. doi: 10.1016/j.jpsychires.2013.05.009. Epub 2013 Jun 3. Erratum in: J Psychiatr Res. 2015 Apr;63:143.

PMID:
23743135
15.

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, Someya Y, Sassa T, Sudo Y, Matsushima E, Iyo M, Tateno Y, Toru M.

Nature. 1997 Feb 13;385(6617):634-6.

PMID:
9024661
16.

Common and differential pathophysiological features accompany comparable cognitive impairments in medication-free patients with schizophrenia and in healthy aging subjects.

Dreher JC, Koch P, Kohn P, Apud J, Weinberger DR, Berman KF.

Biol Psychiatry. 2012 May 15;71(10):890-7. doi: 10.1016/j.biopsych.2012.01.002. Epub 2012 Feb 17.

17.

Dopamine D(1) receptors and age differences in brain activation during working memory.

Bäckman L, Karlsson S, Fischer H, Karlsson P, Brehmer Y, Rieckmann A, MacDonald SW, Farde L, Nyberg L.

Neurobiol Aging. 2011 Oct;32(10):1849-56. doi: 10.1016/j.neurobiolaging.2009.10.018. Epub 2009 Dec 4.

PMID:
19962789
18.

Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study.

Potkin SG, Turner JA, Brown GG, McCarthy G, Greve DN, Glover GH, Manoach DS, Belger A, Diaz M, Wible CG, Ford JM, Mathalon DH, Gollub R, Lauriello J, O'Leary D, van Erp TG, Toga AW, Preda A, Lim KO; FBIRN.

Schizophr Bull. 2009 Jan;35(1):19-31. doi: 10.1093/schbul/sbn162. Epub 2008 Nov 27.

19.

Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia.

Perlstein WM, Carter CS, Noll DC, Cohen JD.

Am J Psychiatry. 2001 Jul;158(7):1105-13.

PMID:
11431233
20.

D1 and D2 receptor antagonist injections in the prefrontal cortex selectively impair spatial learning in mice.

Rinaldi A, Mandillo S, Oliverio A, Mele A.

Neuropsychopharmacology. 2007 Feb;32(2):309-19. Epub 2006 Aug 9.

Supplemental Content

Support Center